
BioXcel Therapeutics BTAI
€ 1.57
0.83%
Quartalsbericht 2025-Q3
hinzugefügt 12.11.2025
BioXcel Therapeutics EV 2011-2026 | BTAI
EV Jährlich BioXcel Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107 M | 70.1 M | 14.1 M | 260 M | 804 M | 261 M | 41.9 M | 1.45 M | 331 K | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 804 M | 331 K | 173 M |
EV anderer Aktien in der Pharmaeinzelhändler
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.82 B | - | 2.43 % | $ 254 M | ||
|
Adagene
ADAG
|
395 M | $ 2.65 | 30.54 % | $ 149 M | ||
|
Acorda Therapeutics
ACOR
|
-13.2 M | - | -24.86 % | $ 820 K | ||
|
BioLineRx Ltd.
BLRX
|
15 M | $ 3.1 | 4.62 % | $ 908 M | ||
|
BioNTech SE
BNTX
|
-6.64 B | $ 116.07 | -2.03 % | $ 27.2 B | ||
|
Aeterna Zentaris
AEZS
|
5.52 M | - | 5.93 % | $ 314 M | ||
|
Burford Capital Limited
BUR
|
3.22 B | $ 9.75 | -1.22 % | $ 1.55 B | ||
|
Alterity Therapeutics Limited
ATHE
|
-28.9 M | $ 3.51 | 7.34 % | $ 8.45 B | ||
|
AgeX Therapeutics
AGE
|
6.28 M | - | -10.17 % | $ 12.2 K | ||
|
Can-Fite BioPharma Ltd.
CANF
|
647 M | $ 4.44 | 6.73 % | $ 9.66 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
1.95 B | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
525 M | - | -13.47 % | $ 169 M | ||
|
Aeglea BioTherapeutics
AGLE
|
725 M | - | - | $ 1.01 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
2 B | $ 25.97 | -0.67 % | $ 1.26 B | ||
|
Midatech Pharma plc
MTP
|
4.79 M | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
3.41 B | - | -1.52 % | $ 24.7 M | ||
|
Akero Therapeutics
AKRO
|
2.99 B | - | - | $ 3.67 B | ||
|
Aptose Biosciences
APTO
|
10.8 M | - | -45.71 % | $ 1.2 M | ||
|
Aravive
ARAV
|
58.2 M | - | -13.39 % | $ 1.45 M | ||
|
Athira Pharma
ATHA
|
-18.3 M | - | - | $ 269 M | ||
|
Akouos
AKUS
|
95.1 M | - | 0.23 % | $ 488 M | ||
|
Corcept Therapeutics Incorporated
CORT
|
6.58 B | $ 44.36 | 7.4 % | $ 4.58 B | ||
|
AVROBIO
AVRO
|
-35.4 M | - | 1083.1 % | $ 745 M | ||
|
Applied Molecular Transport
AMTI
|
7.6 M | - | - | $ 10.1 M | ||
|
Catalyst Pharmaceuticals
CPRX
|
2.05 B | $ 23.81 | -2.62 % | $ 2.82 B | ||
|
Институт стволовых клеток человека
ISKJ
|
14.1 M | - | - | - | ||
|
Ascendis Pharma A/S
ASND
|
726 M | $ 235.38 | 2.94 % | $ 5 B | ||
|
ARCA biopharma
ABIO
|
436 M | - | 1052.0 % | $ 415 M | ||
|
Aytu BioScience
AYTU
|
-15.2 M | $ 2.66 | -1.85 % | $ 16.7 M | ||
|
Acasti Pharma
ACST
|
24 M | - | 4.01 % | $ 150 M | ||
|
Champions Oncology
CSBR
|
125 M | $ 6.76 | -2.45 % | $ 92.3 M | ||
|
Arrowhead Pharmaceuticals
ARWR
|
6.02 B | $ 67.74 | -2.66 % | $ 9.06 B | ||
|
Brickell Biotech
BBI
|
515 K | - | -5.38 % | $ 6.06 M | ||
|
BeiGene, Ltd.
BGNE
|
253 B | - | 0.49 % | $ 251 B | ||
|
Ayala Pharmaceuticals
AYLA
|
5.32 M | - | - | $ 7.46 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
2.15 B | - | -15.15 % | $ 60.3 M | ||
|
AIkido Pharma
AIKI
|
22.8 M | - | 1.93 % | $ 17.4 M | ||
|
Albireo Pharma
ALBO
|
417 M | - | -0.23 % | $ 916 M | ||
|
CureVac N.V.
CVAC
|
3.19 B | - | - | $ 867 M | ||
|
Acer Therapeutics
ACER
|
38.2 M | - | 2.71 % | $ 14 M | ||
|
Bellicum Pharmaceuticals
BLCM
|
-9.74 M | - | -9.72 % | $ 5.89 M | ||
|
Alpine Immune Sciences
ALPN
|
363 M | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
-64.1 M | - | 4.14 % | $ 49.1 M | ||
|
Coherus BioSciences
CHRS
|
929 M | $ 2.07 | 30.19 % | $ 195 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-1.05 M | - | -11.43 % | $ 502 K | ||
|
Biogen
BIIB
|
28.3 B | $ 171.55 | -1.29 % | $ 25 B | ||
|
Bio-Path Holdings
BPTH
|
4.67 M | - | - | $ 100 K | ||
|
BioVie
BIVI
|
-12.6 M | $ 1.19 | -4.8 % | $ 1.76 M | ||
|
Baudax Bio
BXRX
|
29.8 M | - | 0.59 % | $ 63 K |